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Background and aims: The study’s aim was to evaluate the efficacy of endoscopic injection 
sclerotherapy (EIS) compared with endoscopic band ligation (EBL) in treating rectal varices.
Methods: Data from 34 consecutive patients who underwent endoscopic treatments for rectal 
varices were analyzed. The clinical outcomes, including complications, related to EIS or EBL 
retrospectively.
Results: In 25 of the 34 patients, EIS was performed weekly 2–5 times (mean, 2.7), and the 
total amount of sclerosant ranged from 3.2 to 12.0 mL (mean, 5.2 mL). After EIS, colonoscopy 
revealed shrinkage of the rectal varices in all 25 patients, with no complications reported. 
In 9 of the 34 patients, EBL was performed weekly 1–3 times (mean, 2.2), and bands were placed 
on the varices at 2–12 sites (mean, 8.0). After EBL, colonoscopy revealed ulcers and shrinkage 
of the rectal varices in all nine patients, eight of whom experienced no operative complications. 
The overall recurrence rate for rectal varices was 10 of 24 (41.7%), including 5 of 9 (55.6%) 
receiving EBL and 5 of 15 (33.3%) receiving EIS, over a 1-year follow-up period (n = 24). All four 
patients with recurrence of bleeding were EBL cases, versus no EIS cases (P , 0.05).
Conclusion: EIS appears superior to EBL with regard to effectiveness and complications after 
endoscopic treatment of rectal varices.
Keywords: portal hypertension, endoscopic injection sclerotherapy, endoscopic band ligation, 
rectal varices
Introduction
Rectal varices have been reported to occur with high frequency in patients with hepatic 
abnormalities.1–3 Hosking et al reported that 44 of 100 consecutive cirrhotic patients had 
anorectal varices.1 Other studies found that the prevalence of anorectal varices was 78% in 
72 portal hypertensive patients2 and 43% in 103 cirrhotic patients.3 Massive bleeding from 
rectal varices occurs rarely, at a frequency ranging from 0.5% to 3.6%.4–6 Rectal varices 
are an infrequent but potentially serious cause of hematochezia. Although endoscopic 
injection sclerotherapy (EIS) and endoscopic band ligation (EBL) for esophageal varices 
are well-established therapies, there is no standard treatment for rectal varices. In this 
study, we retrospectively evaluated the therapeutic effects and complications of EIS 
versus EBL on rectal varices in patients with portal hypertension.
Patients and methods
Patients
This study retrospectively evaluated 34 consecutive patients with portal hypertension 
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Sapporo Kosei Hospital from April 1996 to December 2009. 
There were 15 males and 19 females, ranging in age from 
38 to 84 years (mean, 67.0 years). Twenty of the 34 patients 
had histories of rectal bleeding, and colonoscopy revealed 
the high-risk sign (red color [RC]-positivity) of variceal 
rupture7 in the other 14 patients. EBL was performed for 
the first nine rectal variceal patients, and EIS was done 
for the next 25 patients because of establishment of EIS 
method for rectal varices. The underlying pathologies caus-
ing portal hypertension included liver cirrhosis (LC) in 
18 patients, cirrhosis associated with hepatocellular carci-
noma (HCC) in seven patients, idiopathic portal hypertension 
(IPH) in four patients, primary biliary cirrhosis (PBC) in 
three patients, and extrahepatic portal vein obstruction (EHO) 
in two patients (Table 1). In terms of the clinical staging 
of cirrhosis, 16 patients were graded Child-Pugh class A, 
16 class B, and 2 class C. The etiologies of LC were: hepatitis 
B surface antigen (HBs Ag)-positivity in four patients, anti-
body to hepatitis C virus (anti-HCV)-positivity in 11 patients, 
alcoholic liver disease in seven patients, sarcoidosis in one 
patient, and unknown in two patients.
All 34 patients with portal hypertension had previously 
received emergency or prophylactic EIS for esophageal 
varices. Seven patients had a history of esophageal variceal 
bleeding, and emergency EIS had been performed in these 
cases. Prophylactic EIS had been performed on 27 patients 
with esophageal varices because of a high risk of bleeding. 
Recent endoscopic findings related to esophageal varices 
were as follows: six cases with small, straight, RC-positive 
varices, and 28 with no varices.
Endoscopic findings for rectal varices
The endoscopic findings for rectal varices were evaluated 
according to the grading system outlined in ‘The General 
Rules for Recording Endoscopic Findings of Esophagogastric 
Varices’ prepared by the Japanese Research Committee 
on Portal Hypertension.8 The form (F) of the varices was 
classified as small and straight (F1), enlarged and tortuous 
(F2), large and coil-shaped (F3), or no varices after treatment 
(F0). The fundamental color of the varices was classified 
as either white (Cw) or blue (Cb). The RC sign referred to 
dilated, small vessels or telangiectasia on the variceal surface. 
Rectal varices with grades of Cb, F2, and RC-positive were 
observed in 31 of the 34 patients, and grades of Cb, F3, and 
RC-positive in the other three patients (Table 1).
The study was performed according to the principles of 
the Declaration of Helsinki. Written informed consent was 
obtained from all patients prior to the procedure. The study 
was approved by the ethics committee of Sapporo Kosei 
Hospital (Sapporo, Japan).
Methods
EIS was performed in 25 patients (14 of whom had a history 
of rectal bleeding, and the remaining 11 patients were deter-
mined to have a high risk of variceal bleeding based on 
endoscopic findings.7 In these EIS-treated patients, the under-
lying pathologies causing portal hypertension included LC 
in 13 patients, cirrhosis associated with HCC in six patients, 
IPH in three patients, PBC in two patients, and EHO in one 
patient. Cirrhosis was graded in 11 patients as Child–Pugh 
class A, in 13 patients as class B, and in one patient as class C 
(Table 1). EIS was performed weekly using 5% ethanolamine 
oleate with iopamidol (EOI), which was injected to rectal 
varices intermittently under fluoroscopy. Figure 1A shows 
Cb, F2, RC-positive rectal varices, and EIS was performed 
under fluoroscopy. The fluoroscopic observation with infu-
sion of 5% EOI was performed to determine the extent of 
the varices (Figures 1B and 1C).
EBL was performed in nine patients (six of whom had a 
history of rectal bleeding, and the remaining three patients 
had a high risk of variceal bleeding based on endoscopic 
findings). In these EBL-treated patients, the underlying 
pathologies causing portal hypertension included LC in five 
patients, cirrhosis associated with HCC in one patient, IPH 
in one patient, PBC in one patient, and EHO in one patient. 
Table 1 Clinicopathological features of patients with rectal varices
Feature EIS (n = 25) EBL (n = 9)
n (%) n (%)
Gender (male/female) 10/15 5/4
rectal bleeding 14/25 (56.0%) 6/9 (66.7%)
Child-Pugh classification
 A 11 5
 B 13  3
 C 1 1
Pathogenesis
  LC  13  5
  LC+hCC  6 1
  PBC 2 1
  EhO 1 1
  iPh 3 1
Endoscopic findings
  Cb 25/25 (100%) 9/9 (100%)
 F 2 22/25 (88.0%) 9/9 (100%)
 F 3 3/25 (12.0%) 0/9 (0%)
  rC(+) 25/25 (100%)  9/9 (100%)
Abbreviations:  Cb,  blue;  LC,  liver  cirrhosis;  hCC,  hepatocellular  carcinoma;   
PBC,  primary  biliary  cirrhosis;  EBL,  endoscopic  band  ligation;  EhO,  extrahepatic 
portal vein obstruction; EiS, endoscopic injection sclerotherapy; iPh, idiopathic portal 
hypertension; F2, enlarged tortuous varices; F3, large, coil-shaped varices; rC, red 
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Cirrhosis was graded in five patients as Child–Pugh class A, 
in three patients as class B, and in one patient as class C 
(Table 1). In these nine patients, EBL was performed weekly 
using a pneumo-activated device (Sumitomo Bakelite, 
Tokyo, Japan), and bands were placed on the varices. An 
overtube was not used during EBL.
EIS and EBL were performed until the rectal varices were 
completely eradicated. We defined variceal recurrence as 
bleeding from rectal varices or possible RC sign. We evalu-
ated the therapeutic effects, complications, and recurrence 
rates after EIS or EBL. We did not use beta blockers in each 
of the EIS and EBL groups.
Statistical analysis
Recurrence rates were calculated by the Kaplan–Meier 
method using StatView® software (SAS® Institute Inc., Cary, 
NC), and data were analyzed using the Breslow–Gehan–
Wilcoxon test for between-group comparisons. A P-value of 
less than 0.05 was considered to be statistically significant.
Results
In 25 of the 34 patients, EIS was performed weekly from 2 
to 5 times (mean, 2.7), and the total amount of sclerosant 
injected ranged from 3.2 to 12.0 mL (mean, 5.2 mL). After EIS, 
colonoscopy revealed shrinkage of the rectal varices (Figure 2) 
in all 25 patients, with no complications reported.
In 9 of the 34 patients, EBL was performed weekly from 1 
to 3 times (mean, 2.2), and bands were placed on the varices 
at 2–12 sites (mean, 8.0). After EBL, colonoscopy revealed 
ulcers and improvement of the varices in the rectum of all 
nine patients. Eight of the nine patients experienced no opera-
tive complications, but colonoscopy revealed bleeding from 
ulcers after EBL in one case (Figure 3). Endoscopic clipping 
was performed on the oozing ulcers in this case.
The overall rate of recurrence of rectal varices over the 
1-year follow-up period (n = 24) after treatments was 10 of 
24 patients (41.7%), including 5 of 9 patients (55.6%) receiv-
ing EBL and 5 of 15 patients (33.3%) receiving EIS. The 
recurrence rate showed no statistically significant difference 
between the EIS group and the EBL group. The recurrence rate 
with bleeding was 4 of 10 patients with recurrent rectal varices 
(40.0%), including 4 of the 5 patients (80.0%) receiving EBL 
but none of the 5 patients (0%) receiving EIS. The recurrence 
rate with bleeding in the EBL group was significantly higher 
than that in the EIS group (P , 0.05) (Figure 4). After the 
treatments for rectal varices, there was no episode of esoph-
agogastric variceal bleeding in all these cases.
Discussion
Esophagogastric varices are considered to be the most com-
mon complication in patients with portal hypertension, while 
ectopic varices (ie, those outside the esophagogastric region) 
are less common. Rectal varices represent portal systemic 
collaterals that are manifested as discrete dilated submucosal 
veins and constitute a pathway for portal venous flow between 
the superior rectal veins of the inferior mesenteric system 
and the middle inferior rectal veins of the iliac system. 
A
B
C
Figure 1 A) Cb, F2, rC-positive rectal varices. B) Fluoroscopic observation with 
infusion of 5% EOi was performed to determine the extent of the varices. C) One 
week after, fluoroscopic observation with infusion of 5% EOI.
Abbreviations: Cb, blue; EiS, endoscopic injection sclerotherapy; EOi, ethanolamine 
oleate with iopamidol; F2, enlarged and tortuous; rC, red color.
Figure 2 After EiS colonoscopy revealed shrinkage of the rectal varices.Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
162
Sato et al
Endoscopic ultrasonography (EUS) has become a useful 
modality for hemodynamic diagnosis of esophagogastric 
varices.9,10 The usefulness of EUS11–13 in the hemodynamic 
diagnosis of rectal varices has been described, and Dhiman 
et al found rectal varices via endoscopy in 43% of patients 
and via EUS in 75% of patients with portal hypertension.13
Endoscopic color Doppler ultrasonography (ECDUS) is 
better equipped than conventional EUS to visualize in detail 
the hemodynamics of esophagogastric varices.14,15 ECDUS is 
useful for detecting rectal varices through color flow images, 
and it optimizes the effectiveness and safety of EIS by mea-
suring the velocity of blood flow in rectal varices.16
Recently, color Doppler ultrasonography has become 
widely accepted for the assessment of the hemodynamics 
of abdominal vascular systems, but few color Doppler find-
ings related to gastrointestinal varices have been reported. 
Komatsuda et al reported the usefulness of color Doppler 
ultrasonography for the diagnosis of gastric and duodenal 
varices,17 and Sato et al concluded that this technology was 
useful for evaluating the hemodynamics of rectal varices.18
Various medical treatments have been used to control 
bleeding from rectal varices, but none of these is currently 
considered to be a standard method. Surgical approaches 
include portosystemic shunting, ligation, and under-running 
suturing.1 Some investigators have reported that interven-
tional radiologic techniques such as transjugular intrahepatic 
portosystemic shunts were successfully employed for rectal 
variceal bleeding.19–21 We have used EIS or EBL to treat 
rectal varices. In this study, we retrospectively evaluated the 
therapeutic effects and rates of recurrence of rectal varices 
after EIS or EBL. Wang et al first reported the usefulness of 
EIS in treating rectal varices and found it to be effective for 
controlling bleeding.22 In our study, we performed EIS in 25 
of the 34 patients, which were successfully treated without 
complications. It is necessary to evaluate the hemodynamics 
of the rectal varices before EIS to avoid severe complications 
such as pulmonary embolism, and the sclerosant should be 
slowly injected under fluoroscopy, taking care to ensure that 
the agent does not flow into the systemic circulation.
EBL was introduced as a new method for treating esopha-
geal varices, and it is reportedly both easier to perform and 
safer than EIS. Several cases of successful treatment of rec-
tal varices using EBL have been reported.23–25 Levine et al 
treated rectal varices initially with EIS, and 1 week later, 
EBL was performed on the remaining rectal varices. These 
investigators described EBL as a safe and effective therapy 
for rectal varices.23
The overall recurrence rate for rectal varices over the 
1-year follow-up period after treatments was 10 of 24 (41.7%). 
We suspected that the high recurrence rate after endoscopic 
therapies was caused by not using the mucosal–fibrosis 
method26 on the rectum. The patients with recurrence included 
5 of the 15 patients (33.3%) receiving EIS and 5 of the 9 
(55.6%) who received EBL. The recurrence rate was not 
significantly different between the EIS group and EBL groups, 
although recurrence tended to be more frequent with EBL. 
Therefore, EBL may be suitable as an initial treatment for 
rectal varices, but it appears that the varices can easily recur 
after EBL.27,28 Shudo et al reported a case report of rectal 
varices that was treated with concurrent EBL and EIS treat-
ment.29 Furthermore, after EBL, bleeding from ulcers in need 
of endoscopic clipping occurred in one of our cases. The recur-
rence rate for bleeding in the EBL group was significantly 
higher than in the EIS group. All four patients with recurrence 
of bleeding had been treated using EBL. The literature does 
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Figure 4 recurrence with bleeding-free survival rate was calculated by the Kaplan–
Meier method for between-group comparisons.
Figure 3 Colonoscopy revealed bleeding from ulcers after endoscopic band ligation.Clinical and Experimental Gastroenterology
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not include reports of long-term comparative follow-up of 
large numbers of patients with rectal varices treated using 
EIS in comparison with EBL. Our report is the first of its kind 
including the results of long-term follow-up of relatively large 
numbers of portal hypertensive patients with rectal varices 
treated using endoscopic methods. In general, beta blockers 
are used effectively for prophylaxis of esophageal varices in 
Europe and North America. However, there is no report on 
the role of beta blocker use for rectal varices.
In conclusion, EIS appears to be superior to EBL with 
regard to long-term effectiveness and complications follow-
ing endoscopic treatment of rectal varices in patients with 
portal hypertension. More investigations are necessary in 
larger numbers of patients before evidence-based treatment 
recommendations can be made.
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